| Product NDC: | 43353-744 | 
| Proprietary Name: | Levitra | 
| Non Proprietary Name: | vardenafil hydrochloride | 
| Active Ingredient(s): | 5 mg/1 & nbsp; vardenafil hydrochloride | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET, FILM COATED | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 43353-744 | 
| Labeler Name: | APHENA PHARMA SOLUTIONS - TENNESSEE, INC. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA021400 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 20110422 | 
| Package NDC: | 43353-744-06 | 
| Package Description: | 6 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43353-744-06) | 
| NDC Code | 43353-744-06 | 
| Proprietary Name | Levitra | 
| Package Description | 6 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43353-744-06) | 
| Product NDC | 43353-744 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | vardenafil hydrochloride | 
| Dosage Form Name | TABLET, FILM COATED | 
| Route Name | ORAL | 
| Start Marketing Date | 20110422 | 
| Marketing Category Name | NDA | 
| Labeler Name | APHENA PHARMA SOLUTIONS - TENNESSEE, INC. | 
| Substance Name | VARDENAFIL HYDROCHLORIDE | 
| Strength Number | 5 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] |